Navigation Links
NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
Date:11/13/2008

ANN ARBOR, Mich., Nov. 13 /PRNewswire/ -- NanoBio Corporation announced today that it will present new data in four presentations that detail milestones in its clinical and preclinical development programs in onychomycosis, acne, herpes labialis and genital herpes during the American Association of Pharmaceutical Scientists (AAPS) meeting November 16-20, 2008 in Atlanta, GA.

The company's presentation schedule during the conference:

Tuesday, November 18, 1:00 PM - 5:00 PM

-- In-vitro Skin Permeation of Novel Antimicrobial Nanoemulsion

Formulations

-- Lateral Diffusion of a Novel Antifungal Nanoemulsion In-vitro Human

Cadaver Skin

-- Pharmacokinetics of a Novel Topical Antimicrobial Nanoemulsion

Wednesday, November 19, 1:00 - 5:00 PM

-- Long Term Stability of NB-001: A Novel Antiviral Nanoemulsion

These studies confirm the skin permeation, overall safety and long-term stability of nanoemulsion-based therapies. The data support the continued development of NanoBio treatments for a wide range of skin and mucosal infections, including NanoBio's lead products identified above as well as treatments for tinea capitis (ringworm), molluscum contagiosum (pox virus warts) and other topical fungal, bacterial and viral infections.

About NanoBio

NanoBio(R) Corp. is a privately held biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat(TM) technology platform. The company's lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), acne, and a broad platform of mucosal vaccines. NanoBio has demonstrated robust efficacy and safety in randomized, double-blind, placebo-controlled phase 2a and phase 2b studies involving over 800 subjects with recurrent herpes labialis. A large phase 2 trial is nearing completion in onychomycosis and clinical trials are p
'/>"/>

SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NanoBio Expands Drug Development Team for Its Anti-Infective Products
2. Dr. Joyce Sutcliffe Joins the NanoBio Team as Vice President of Research
3. David M. Stout Joins NanoBio Corporations Board of Directors
4. FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008
5. Daniel B. Dubin, M.D., Joins NanoBio Corp.s Board of Directors
6. NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008
7. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
8. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
9. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
10. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
11. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Research and Markets ... Synthetic Biology Market 2014-2018" report to their offering. ... The term synthetic biology covers the designing and engineering ... well as the redesigning of natural biological systems that ... be a form of extreme genetic engineering because it ...
(Date:7/28/2014)... & Boston, MA (PRWEB) July 28, 2014 ... agreements with two researchers to further develop potential treatments ... malignant brain tumor, in combination with their patented vaccine ... ITI and Duke University, are based on the work ... Division of Neurosurgery at The Preston Robert Tisch Brain ...
(Date:7/28/2014)... 2014 The global market for biotechnology ... according to a new study by Grand View Research, ... for effective vaccines and drugs in an attempt to ... is expected to drive market demand over the next ... productivity via the use of genetically engineered seeds is ...
(Date:7/28/2014)... The National Model Aviation Museum, located at ... to announce that it has been granted full civilian ... States Air Force. , The certification is the culmination ... spring with an on-site inspection by Sarah Sessions, Museum ... National Museum of the United States Air Force ...
Breaking Biology Technology:Global Synthetic Biology Market 2014-2018 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4AMA’s National Model Aviation Museum Granted Full Civilian Museum Certification by the National Museum of the United States Air Force 2
... revenue growth ... - Product revenues increased 30% to a record $59.7 ... - Shipped 28,600 new pulse oximeters ... increased 104%, IRVINE, Calif., April 29, 2008 Masimo,Corporation (Nasdaq: MASI ), the ...
... to transmit medical images via cellular phones that has ... Jerusalem researcher has the potential to provide sophisticated radiological ... population lacking access to such technology. This would include ... rural areas of developed countries who live considerable distances ...
... /PRNewswire-FirstCall/,-- Shire plc ("Shire") (LSE: SHP, NASDAQ: SHPGY), ... publication of the,Prospectus by Shire Limited on 16 ... to 700,000,000 Ordinary Shares of 5 pence each ... be made available through,publication on Shire,s website: ...
Cached Biology Technology:Masimo Reports First Quarter 2008 Financial Results 2Masimo Reports First Quarter 2008 Financial Results 3Masimo Reports First Quarter 2008 Financial Results 4Masimo Reports First Quarter 2008 Financial Results 5Masimo Reports First Quarter 2008 Financial Results 6Masimo Reports First Quarter 2008 Financial Results 7Masimo Reports First Quarter 2008 Financial Results 8Masimo Reports First Quarter 2008 Financial Results 9Masimo Reports First Quarter 2008 Financial Results 10Researchers develop method for transmitting medical images via cell phones 2Researchers develop method for transmitting medical images via cell phones 3Researchers develop method for transmitting medical images via cell phones 4Publication of Supplementary Prospectus 2Publication of Supplementary Prospectus 3Publication of Supplementary Prospectus 4
(Date:7/28/2014)... Brain & Behavior Research Foundation today announced the ... recognizing exceptional clinical and basic research by young ... Investigator Grants. The grants enable early career scientists ... research for the prevention, early detection, treatment, and ... four people. , Six young scientistswinners of the ...
(Date:7/28/2014)... 15% of adults suffer from fertility problems, many of ... a paradox: We might expect such genes, which reduce ... population. Research at the Weizmann Institute of Science that ... have solved this riddle. Not only can it explain ... open new avenues in understanding the causes of genetic ...
(Date:7/27/2014)... has revealed that nicotine and cotinine, a metabolite of ... certain carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or ... and ultimately ends up in the tobacco smoke. Once ... where it is activated by a variety of enzymes ... revealed that nicotine can partially interfere with the activation ...
Breaking Biology News(10 mins):The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4Mutations from Venus, mutations from Mars 2Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... forces apparatus and an atomic force microscope, researchers at UC ... interactions, leading to insights into demyelinating diseases, such as multiple ... the National Academy of the Sciences . For a ... nerve cells that run throughout our bodies must be ...
... GA--Managing the quality and quantity of freshwater resources ... of the 21st century. Global population growth and ... water resources among domestic, industrial, and agricultural users. ... while recognizing the limitations of freshwater resources, many ...
... on climate protection and political declarations of intent, ... the contrary, they continue to increase. With a ... markets such as India and China the emission ... to be unlikely. Therefore, large-scale methods to artificially ...
Cached Biology News:Unhealthy attachments 2Unhealthy attachments 3Report details multiple commercial uses of wireless sensor networks 2Climate engineering: Minor potential, major side effects 2Climate engineering: Minor potential, major side effects 3
WTAP Antibody...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Biology Products: